Cymer Reaches New 52-Week High (CYMI)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Cymer (Nasdaq: CYMI) hit a new 52-week high Tuesday as it is currently trading at $115.50, above its previous 52-week high of $113.66 with 3,241 shares traded as of 9:30 a.m. ET. Average volume has been 338,600 shares over the past 30 days.

Cymer has a market cap of $3.58 billion and is part of the technology sector and electronics industry. Shares are up 25.3% year to date as of the close of trading on Friday.

Cymer, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of light sources for the manufacturers of photolithography tools in the semiconductor equipment industry.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Cymer as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. You can view the full Cymer Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.

null

More from Markets

US Stock Futures Gain as China Tax Pledge Sparks Rally, Steadies Global Markets

US Stock Futures Gain as China Tax Pledge Sparks Rally, Steadies Global Markets

Parsons Resigns From CBS Board due to Health Reasons

Parsons Resigns From CBS Board due to Health Reasons

Data Regulation on FAANG's Could Just Be Underway: Cramer's Investing Teach-in

Data Regulation on FAANG's Could Just Be Underway: Cramer's Investing Teach-in

Your Need to Know - Forward Look

Your Need to Know - Forward Look

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

3 Things Investors Can Do to Stay Strategic When the Market's Volatile